Pancreatin

Pancreatin (170mg) with Bile Salts (Sodium Tauroglycocholate 65mg) and/or Dimethicone (80mg) Tablets is a comprehensive digestive enzyme and emulsifying formulation. Pancreatin provides amylase, lipase, and protease; tauroglycocholate emulsifies dietary fats and activates pancreatic lipase for optimal absorption; dimethicone reduces surface tension of trapped gas bubbles. Indicated for exocrine pancreatic insufficiency, chronic pancreatitis, dyspepsia, fatty food intolerance, and flatulent indigestion.

Pancreatin (170mg) with Bile Salts (Sodium Tauroglycocholate 65mg) and/or Dimethicone (80mg) Tablets is a comprehensive digestive enzyme and emulsifying formulation. Pancreatin provides amylase, lipase, and protease; tauroglycocholate emulsifies dietary fats and activates pancreatic lipase for optimal absorption; dimethicone reduces surface tension of trapped gas bubbles. Indicated for exocrine pancreatic insufficiency, chronic pancreatitis, dyspepsia, fatty food intolerance, and flatulent indigestion.

L-Ornithine L-Aspartate (150mg) and Pancreatin (100mg) Tablets combines an ammonia-detoxifying metabolic amino acid with digestive pancreatic enzymes. LOLA stimulates urea cycle carbamoyl phosphate synthetase in hepatocytes and glutamine synthesis in skeletal muscle, clearing neurotoxic ammonia. Pancreatin supplies amylase, lipase, and protease to assist nutrient breakdown in patients with compromised digestion. Indicated for hepatic dysfunction, fatty liver, subclinical hepatic encephalopathy, and digestive insufficiency associated with liver cirrhosis.

Pancreatin Gastro-Resistant Capsules (10,000, 25,000, 40,000 Lipase Units) is an oral porcine pancreatic enzyme replacement therapy (PERT) on the WHO Model List of Essential Medicines. Each capsule contains enteric-coated mini-microspheres designed to withstand gastric acid and dissolve rapidly at duodenal pH > 5.5, releasing standardized concentrations of lipase, amylase, and protease for physiological digestion of lipids, carbohydrates, and proteins. Indicated for exocrine pancreatic insufficiency (EPI) associated with cystic fibrosis, chronic pancreatitis, pancreatectomy, and gastrectomy.

Pancreatin Gastro-Resistant Capsules (10,000, 25,000, 40,000 Lipase Units) is an oral porcine pancreatic enzyme replacement therapy (PERT) on the WHO Model List of Essential Medicines. Each capsule contains enteric-coated mini-microspheres designed to withstand gastric acid and dissolve rapidly at duodenal pH > 5.5, releasing standardized concentrations of lipase, amylase, and protease for physiological digestion of lipids, carbohydrates, and proteins. Indicated for exocrine pancreatic insufficiency (EPI) associated with cystic fibrosis, chronic pancreatitis, pancreatectomy, and gastrectomy.

L-Ornithine L-Aspartate (150mg) and Pancreatin (100mg) Tablets combines an ammonia-detoxifying metabolic amino acid with digestive pancreatic enzymes. LOLA stimulates urea cycle carbamoyl phosphate synthetase in hepatocytes and glutamine synthesis in skeletal muscle, clearing neurotoxic ammonia. Pancreatin supplies amylase, lipase, and protease to assist nutrient breakdown in patients with compromised digestion. Indicated for hepatic dysfunction, fatty liver, subclinical hepatic encephalopathy, and digestive insufficiency associated with liver cirrhosis.

Pancreatin Gastro-Resistant Capsules (10,000, 25,000, 40,000 Lipase Units) is an oral porcine pancreatic enzyme replacement therapy (PERT) on the WHO Model List of Essential Medicines. Each capsule contains enteric-coated mini-microspheres designed to withstand gastric acid and dissolve rapidly at duodenal pH > 5.5, releasing standardized concentrations of lipase, amylase, and protease for physiological digestion of lipids, carbohydrates, and proteins. Indicated for exocrine pancreatic insufficiency (EPI) associated with cystic fibrosis, chronic pancreatitis, pancreatectomy, and gastrectomy.